Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Quarterly Financial Performance and Results
TECH logo

Bio-Techne Prepares $1 Billion Wilson Wolf Acquisition Amid Flat Q2 Revenue

TECH10-QFiling Date: 2/4/2026
Bio-Techne Corporation
Description

What this story covers

Bio-Techne reported flat quarterly revenue of $295.9 million, navigating product mix challenges and divestitures. Despite stagnant growth, the company improved diagnostics margins to 10.4%, reduced debt, and maintained liquidity for its upcoming $1 billion Wilson Wolf acquisition.

Story snapshot

CompanyBio-Techne Corporation
TickerTECH
VariantStandard detailed
Duration18:10
Filing type10-Q
PeriodQ1 2025
IndustryHealthcare & Pharmaceuticals
Accession0001104659-26-010335
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-QView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in